Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae.
暂无分享,去创建一个
N. Soni | R. Clark | K. Marsh | Y. Gu | S. Djurić | G. Stone | Zhenkun Ma | A. Nilius | T. Marron | Hong Yong
[1] Hiroshi Ikuta,et al. In vitro and in vivo antibacterial activities of the tricyclic ketolide TE-802 and its analogs. , 2004, The Journal of antibiotics.
[2] M. Mitten,et al. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides. , 2004, Bioorganic & medicinal chemistry letters.
[3] G. Stone,et al. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens. , 2003, Journal of medicinal chemistry.
[4] Suoming Zhang,et al. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. , 2001, Journal of medicinal chemistry.
[5] K. Matsumoto,et al. Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs. , 2001, The Journal of antibiotics.
[6] P. Rhomberg,et al. Antimicrobial Resistance among Clinical Isolates ofStreptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995 , 2001, Antimicrobial Agents and Chemotherapy.
[7] R. Clark,et al. Synthesis of 2-fluoro-6-O-propargyl-11,12-carbamate ketolides. A novel class of antibiotics. , 2000, Organic letters.
[8] R. Clark,et al. Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivatives. , 2000, Bioorganic & Medicinal Chemistry Letters.
[9] Zhenkun Ma and Peter A. Nemoto. Discovery and Development of Ketolides as a New Generation of Macrolide Antimicrobial Agents , 2002 .